J. Melo

发表

Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571

F. Lacombe, J. Reiffers, P. Berthaud, 2002, Leukemia.

Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia

S. Bose, J. Goldman, J. Melo, 1999, Leukemia.

Lack of reciprocal translocation in BCR-ABL positive Ph-negative chronic myeloid leukaemia.

A. Chase, B. Garicochea, J. Goldman, 1994, Leukemia.

Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs

J. Goldman, AJ Tipping, FX Mahon, 2002, Leukemia.

Investigation on the role of the ATM gene in chronic myeloid leukaemia

M. Yuille, J. Goldman, A. Kumberová, 2001, Leukemia.

Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia

T. Vulliamy, J. Goldman, J. Kaeda, 1997, Leukemia.

SOCS 2 is dispensable for BCR / ABL 1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function

T. Fioretos, M. Ehinger, D. Bryder, 2012 .

Expression of interferon regulatory factor (IRF) genes and response to interferon-α in chronic myeloid leukaemia

M. Gordon, R. Hehlmann, A. Hochhaus, 1997, Leukemia.

Abnormal patterns of immunoglobulin heavy chain gene DNA fingerprinting during chronic phase chronic myeloid leukemia.

Richard Szydlo, J. Goldman, A. Spencer, 1999, Leukemia & lymphoma.

The p24 leucocyte membrane antigen: Modulation associated with lymphocyte activation and differentiation

H. Zola, S. Neoh, H. Zowtyj, 1989, Immunology and cell biology.

The ABL-BCR Fusion Gene Is Expressed in Chronic Myeloid Leukemia

J. Melo, J. Goldman, N. Cross, 1993 .

Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate

J. Melo, W. Bornmann, D. Veach, 2003, Leukemia.